ArticleFrontiers in nutrition2026
Frailty, social disconnection, metabolomic signatures, and incident peripheral artery disease in type 2 diabetes: a prospective cohort study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Frailty and social disconnection may increase vascular risk in type 2 diabetes mellitus (T2DM), but their associations with peripheral artery disease (PAD) and related metabolic pathways remain unclear. Methods: This secondary analysis of prospectively collected data from the UK Biobank included 22,582 participants with T2DM and without PAD at baseline. Frailty was defined using an adapted Fried phenotype, and social disconnection was assessed using measures of loneliness and social isolation. Cox proportional hazards models examined their separate and joint associations with incident PAD. Among 21,986 participants with nuclear magnetic resonance (NMR) metabolomic data, exposure-specific metabolomic risk scores (MRSs) were developed using least absolute shrinkage and selection operator Cox (LASSO-Cox) regression in a 70% training set and evaluated in a 30% validation set. Exploratory mediation analyses were performed in the validation set. Extreme gradient boosting (XGBoost) models with Shapley additive explanations (SHAP) were used to explore predictive patterns. Results: During a mean follow-up of 14.43 years, 1,873 incident PAD cases occurred. In the mutually adjusted model, loneliness [hazard ratio (HR), 1.19; 95% confidence interval (CI), 1.03-1.38], social isolation (HR, 1.24; 95% CI, 1.10-1.41), pre-frailty (HR, 1.22; 95% CI, 1.10-1.36), and frailty (HR, 2.02; 95% CI, 1.75-2.34) remained associated with incident PAD. Participants with frailty and either loneliness or social isolation had the highest PAD risk. In the validation set, the frailty-, loneliness-, and social isolation-related metabolomic risk scores were associated with incident PAD, with HRs per standard deviation increase of 1.22 (95% CI, 1.11-1.34), 1.23 (95% CI, 1.12-1.34), and 1.22 (95% CI, 1.11-1.33), respectively. Exploratory mediation analyses indicated that these scores statistically accounted for 16.6, 20.4, and 22.6% of the corresponding associations with PAD, respectively. Conclusion: Frailty, loneliness, and social isolation remained associated with incident PAD after mutual adjustment among individuals with T2DM. Training-derived metabolomic scores were associated with PAD in the validation set and statistically accounted for modest proportions of these associations. These findings support the potential relevance of physical vulnerability and social disconnection to PAD risk, while the metabolomic findings require external validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.